Frank Thomas
President bij ORCHARD THERAPEUTICS PLC
Vermogen: 80 750 $ op 29-02-2024
Profiel
Frank E.
Thomas holds the position of President, Chief Operating & Financial Officer at Orchard Therapeutics Plc and Chief Financial & Business Officer at Orchard Therapeutics (Europe) Ltd.
Mr. Thomas is also on the board of Spero Therapeutics, Inc., Orchard Therapeutics North America and Larimar Therapeutics, Inc.
In his past career he held the position of Chief Operating Officer & Senior Vice President for Molecular Biometrics, Inc., Controller & Finance Director at Mechanical Dynamics, Inc., Chief Financial Officer & VP-Investor Relations at Esperion Therapeutics, Inc., President, Chief Executive Officer & Director at Critical Therapeutics, Inc., President & Chief Operating Officer at AMAG Pharmaceuticals, Inc. and Principal at Arthur Andersen LLP.
He received an undergraduate degree from the University of Michigan.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
SPERO THERAPEUTICS, INC.
0.07% | 05-10-2023 | 35 000 ( 0.07% ) | 57 750 $ | 29-02-2024 |
14-02-2024 | 2 000 ( 0.00% ) | 23 000 $ | 29-02-2024 |
Actieve functies van Frank Thomas
Bedrijven | Functie | Begin |
---|---|---|
SPERO THERAPEUTICS, INC. | Director/Board Member | 06-09-2017 |
ORCHARD THERAPEUTICS PLC | President | 18-03-2020 |
LARIMAR THERAPEUTICS, INC. | Director/Board Member | 28-05-2020 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Director of Finance/CFO | 01-01-2018 |
Eerdere bekende functies van Frank Thomas
Bedrijven | Functie | Einde |
---|---|---|
AMAG PHARMACEUTICALS, INC. | Chief Executive Officer | 14-05-2012 |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Director/Board Member | 01-01-2015 |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Director of Finance/CFO | 18-01-2010 |
Critical Therapeutics, Inc. | Chief Executive Officer | 31-03-2008 |
ESPERION THERAPEUTICS, INC. | Director of Finance/CFO | 01-04-2004 |
Opleiding van Frank Thomas
University of Michigan | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ESPERION THERAPEUTICS, INC. | Health Technology |
SPERO THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 10 |
---|---|
Mechanical Dynamics, Inc.
Mechanical Dynamics, Inc. Information Technology ServicesTechnology Services Part of Hexagon AB, Mechanical Dynamics, Inc. develops, markets, and supports virtual prototyping solutions. The private company is based in Ann Arbor, MI. The company was founded by Michael E. Korybalski. Mechanical Dynamics was acquired by MSC Software Corp., part of Hexagon AB from April 26, 2017 on May 14, 2002 for $117 million. | Technology Services |
Critical Therapeutics, Inc. | Health Technology |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Commercial Services |
Zafgen, Inc.
Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
Larimar Therapeutics, Inc. |